Italy authorizes parallel import of Efexor 37.5 mg from Poland
Italy's medicines agency AIFA has authorized BB Farma S.r.l. of Samarate to import the antidepressant Efexor from Poland under a separate Italian permit. The authorization, set out in determination no. 630 of 15 October 2026, covers a 37.5 mg prolonged-release capsule sold in packs of 28. A parallel import means the same medicine already approved in another country is brought into Italy and sold there with an Italian label.
This summary was generated by AI; the official source prevails.
What does it mean?
Italy now allows a company to bring in a version of the Efexor 37.5 mg capsule that is already sold in Poland, and sell it in Italian pharmacies. The capsules come with Italian labels and leaflets. Efexor is a prescription-only medicine that is not covered by the national health system.
Who is affected?
Patients who take or are prescribed Efexor 37.5 mg in Italy, and pharmacies that sell it.